![]() Earthtimes.org | UCB to Buy Germany's Schwarz Pharma for EU4.4 Billion (Update3) Bloomberg - UCB SA the Belgian maker of the allergy drug Zyrtec agreed to buy Germany's Schwarz Pharma AG for 4.4 billion euros ($5.6 billion) in cash and stock to gain medicines ... Brussels shares AFX at a glance outlook UCB to buy Schwarz Pharma for $5.6 billion |